levodopa dose adjustment versus adjunctive therapy in parkinson’s disease
Published 2 years ago • 21K plays • Length 2:35Download video MP4
Download video MP3
Similar videos
-
2:00
adjunctive mao-b or comt inhibitors to optimize levodopa treatment in pd
-
1:13
extending the efficacy of levodopa in patients with parkinson’s disease
-
2:20
phase ii study of ne3107 in levodopa/carbidopa-treated patients with parkinson's disease
-
2:37
long-term effectiveness of levodopa-carbidopa intestinal gel in parkinson's disease
-
0:50
subcutaneous levodopa/carbidopa infusion for parkinson's disease
-
3:32
adequately treating parkinson disease with levodopa
-
0:50
benefits of combining levodopa with carbidopa in parkinsonism
-
9:31
challenges faced in early parkinson’s disease management and the resurgence of levodopa
-
3:02
improvements to levodopa-based treatments for parkinson’s disease
-
1:27
updates on levodopa infusion therapies for advanced parkinson’s disease
-
7:07
optimizing levodopa-carbidopa intestinal gel dosing in parkinson's
-
1:43
update on the adoption study: opicapone in parkinson’s disease
-
4:56
ask the md: myths about levodopa
-
0:18
trap: symptoms of parkinson disease | medical mnemonic | merck manual professional version
-
6:18
my parkinson's body & timing when to take levodopa/carbidopa
-
38:05
parkinson's medications - part 1: levodopa
-
4:39
levodopa and the pharmacological revolution in parkinson's disease
-
3:31
nd0612 vs oral immediate-release levodopa/carbidopa in patients with pd and motor fluctuations
-
11:04
will parkinson's disease therapy move past carbidopa-levodopa?